Brincidofovir-d 6

Overview

Brincidofovir -d 6 (CMX001-d 6 ) is the deuterium labeled Brincidofovir ( HY-14532 ). Brincidofovir (CMX001), the lipid-conjugated prodrug of Cidofovir ( HY-17438 ), is an orally available, long-acting antiviral . Brincidofovir shows activity against a broad spectrum of DNA viruses including cytomegalovirus ( CMV ), adenovirus (ADV), varicella zoster virus, herpes simplex virus, polyomaviruses, papillomaviruses, poxviruses, and mixed double-stranded DNA virus infections. Brincidofovir , an oral antiviral in late stage development, has proven effective against orthopoxviruses in vitro and in vivo..

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > Orthopoxvirus | Products > Signaling Pathways > CMV | Products > Signaling Pathways > HSV

Product Information

• Catalog No.: HY-14532S
• CAS No.: 1917374-64-1
• Molecular Formula: C27H46D6N3O7P
• Molecular Weight: 567.73
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source